Related Experiment Video
Updated: Jun 5, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Clinical, etiological, and therapeutic profile of early-onset absence seizures: A case series analysis
Patrizia Bergonzini1, Elisa Caramaschi1, Alessandra Spallino1
1Pediatric Unit, Department of Medical and Surgical Sciences of Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena 41121, Italy.
Insights
Early-onset absence epilepsy (EOAE) in children under four often has a good prognosis with medication. Atypical absence seizures in this age group present more complex challenges, including genetic factors and poorer neurocognitive outcomes.
Area of Science:
- Neurology
- Genetics
- Pediatrics
Background:
- Childhood Absence Epilepsy (CAE) typically starts between ages 4-10.
- Early-onset Absence Epilepsy (EOAE) begins before age 4, often with good treatment outcomes.
- Atypical absence seizures are longer, may include motor symptoms, and are linked to severe conditions.
Purpose of the Study:
- Delineate features of EOAE and early-onset atypical absence seizures.
- Facilitate prompt diagnosis, especially of genetic causes.
- Optimize patient outcomes through precision therapies.
Main Methods:
- Retrospective study of 23 pediatric patients with absence epilepsy onset before age 4.
- Evaluation at the Neuropediatrics Outpatient Clinic of Policlinico of Modena.
- Focus on clinical and electroencephalographic phenotypes, genetic abnormalities, and treatment response.
Main Results:
- Children with atypical absences showed complex phenotypes, frequent genetic abnormalities, and less favorable neurocognitive prognosis.
- Half of the atypical absence subgroup were pharmacoresistant.
- All EOAE cases achieved seizure freedom, indicating a benign course.
Conclusions:
- EOAE generally has a favorable prognosis, consistent with existing literature.
- Early-onset atypical absence seizures present significant challenges, including genetic links and pharmacoresistance.
- Identifying genetic aberrations is crucial for tailored interventions and improved outcomes in pediatric absence epilepsy.
Abstract:
Typical absence seizures represent a distinctive form of epileptic activity typically observed in pediatric populations, predominantly manifesting between the ages of 4 and 10, constituting Childhood Absence Epilepsy (CAE). However, a subset of patients presents with Early-onset Absence Epilepsy (EOAE), characterized by seizure onset before the fourth year of life, often displaying favorable outcomes with antiseizure medication. Conversely, atypical absence seizures exhibit prolonged duration and frequently entail tonic, atonic, or myoclonic motor elements, suggesting a more severe clinical course, commonly associated with epileptic encephalopathies of childhood onset. Recent genetic investigations have highlighted the involvement of specific genes, notably the SLC1A2 mutation, identified in 10 % of EOAE cases, underlying the GLUT1 deficiency syndrome. Timely recognition of such genetic anomalies facilitates tailored interventions, including ketogenic dietary regimes, shown to ameliorate epileptic symptomatology and neurocognitive sequelae. This retrospective study aimed to delineate the distinct features of EOAE and early-onset atypical absence seizures, facilitating prompt diagnosis, particularly emphasizing genetic aberrations, and initiating precision therapeutic approaches to optimize patient outcomes. Evaluation of 23 patients with absence epilepsy onset within the first four years of life, conducted at the Neuropediatrics Outpatient Clinic of the Policlinico of Modena, revealed that children with atypical absences often exhibit a complex clinical and electroencephalographic phenotype, frequently associated with genetic abnormalities. Notably, neurocognitive prognosis appears less favorable in this subgroup, with half of the patients displaying pharmacoresistance. In contrast, all EOAE cases demonstrated seizure freedom, corroborating previous literature suggesting a relatively benign clinical course in these individuals.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Arteries of the Lower Limbs
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

